PD-1 Overexpression in Sézary Syndrome Is Epigenetically Regulated
J Invest Dermatol
.
2023 Dec;143(12):2538-2541.e7.
doi: 10.1016/j.jid.2023.03.1687.
Epub 2023 Jun 2.
Authors
Safa Najidh
1
,
Willem H Zoutman
2
,
Anne M R Schrader
3
,
Rein Willemze
2
,
Cornelis P Tensen
2
,
Maarten H Vermeer
2
Affiliations
1
Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: s.najidh@lumc.nl.
2
Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
3
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
PMID:
37270066
DOI:
10.1016/j.jid.2023.03.1687
No abstract available
MeSH terms
Humans
Programmed Cell Death 1 Receptor / genetics
Sezary Syndrome* / genetics
Skin Neoplasms* / genetics
Substances
Programmed Cell Death 1 Receptor